Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas (PLoS ONE (2018) 13:6 (e0197610) DOI: 10.1371/journal.pone.0197610)

Olivia Adams; Félice A. Janser; Bastian Dislich; Sabina Berezowska; Magali Humbert; Christian A. Seiler; Dino Kro; Julia Slotta-Huspenina; Marcus Feith; Katja Ott; Mario P. Tschan; Rupert Langer

doi:10.1371/journal.pone.0224832

Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas (PLoS ONE (2018) 13:6 (e0197610) DOI: 10.1371/journal.pone.0197610)

Olivia Adams, Félice A. Janser, Bastian Dislich, Sabina Berezowska, Magali Humbert, Christian A. Seiler, Dino Kro, Julia Slotta-Huspenina, Marcus Feith, Katja Ott, Mario P. Tschan, Rupert Langer

Department of Surgery

Research output: Contribution to journal › Comment/debate

Abstract

The seventh author's name is spelled incorrectly. The correct name is: Dino Kröll.

Original language	English
Article number	e0224832
Journal	PLoS ONE
Volume	14
Issue number	10
DOIs	https://doi.org/10.1371/journal.pone.0224832
State	Published - 1 Oct 2019

Access to Document

10.1371/journal.pone.0224832

Fingerprint

Dive into the research topics of 'Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas (PLoS ONE (2018) 13:6 (e0197610) DOI: 10.1371/journal.pone.0197610)'. Together they form a unique fingerprint.

Cite this

Adams, O., Janser, F. A., Dislich, B., Berezowska, S., Humbert, M., Seiler, C. A., Kro, D., Slotta-Huspenina, J., Feith, M., Ott, K., Tschan, M. P., & Langer, R. (2019). Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas (PLoS ONE (2018) 13:6 (e0197610) DOI: 10.1371/journal.pone.0197610). PLoS ONE, 14(10), Article e0224832. https://doi.org/10.1371/journal.pone.0224832

@article{42249f9647684d82a43aa5aec1a5e05d,

title = "Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas (PLoS ONE (2018) 13:6 (e0197610) DOI: 10.1371/journal.pone.0197610)",

abstract = "The seventh author's name is spelled incorrectly. The correct name is: Dino Kr{\"o}ll.",

author = "Olivia Adams and Janser, {F{\'e}lice A.} and Bastian Dislich and Sabina Berezowska and Magali Humbert and Seiler, {Christian A.} and Dino Kro and Julia Slotta-Huspenina and Marcus Feith and Katja Ott and Tschan, {Mario P.} and Rupert Langer",

note = "Publisher Copyright: {\textcopyright} 2019 Adams et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",

year = "2019",

month = oct,

day = "1",

doi = "10.1371/journal.pone.0224832",

language = "English",

volume = "14",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "10",

}

Adams, O, Janser, FA, Dislich, B, Berezowska, S, Humbert, M, Seiler, CA, Kro, D, Slotta-Huspenina, J, Feith, M, Ott, K, Tschan, MP & Langer, R 2019, 'Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas (PLoS ONE (2018) 13:6 (e0197610) DOI: 10.1371/journal.pone.0197610)', PLoS ONE, vol. 14, no. 10, e0224832. https://doi.org/10.1371/journal.pone.0224832

Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas (PLoS ONE (2018) 13:6 (e0197610) DOI: 10.1371/journal.pone.0197610). / Adams, Olivia; Janser, Félice A.; Dislich, Bastian et al.
In: PLoS ONE, Vol. 14, No. 10, e0224832, 01.10.2019.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction

T2 - A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas (PLoS ONE (2018) 13:6 (e0197610) DOI: 10.1371/journal.pone.0197610)

AU - Adams, Olivia

AU - Janser, Félice A.

AU - Dislich, Bastian

AU - Berezowska, Sabina

AU - Humbert, Magali

AU - Seiler, Christian A.

AU - Kro, Dino

AU - Slotta-Huspenina, Julia

AU - Feith, Marcus

AU - Ott, Katja

AU - Tschan, Mario P.

AU - Langer, Rupert

N1 - Publisher Copyright: © 2019 Adams et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PY - 2019/10/1

Y1 - 2019/10/1

N2 - The seventh author's name is spelled incorrectly. The correct name is: Dino Kröll.

AB - The seventh author's name is spelled incorrectly. The correct name is: Dino Kröll.

UR - http://www.scopus.com/inward/record.url?scp=85074355520&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0224832

DO - 10.1371/journal.pone.0224832

M3 - Comment/debate

C2 - 31665193

AN - SCOPUS:85074355520

SN - 1932-6203

VL - 14

JO - PLoS ONE

JF - PLoS ONE

IS - 10

M1 - e0224832

ER -

Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas (PLoS ONE (2018) 13:6 (e0197610) DOI: 10.1371/journal.pone.0197610)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this